Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Sutent in Metastatic Melanoma Patients With KIT Aberrations.

NCT00631618 is registered in ClinicalTrials.gov with California Pacific Medical Center Research Institute as lead sponsor.

NCT NCT00631618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00631618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Sutent in Metastatic Melanoma Patients With KIT Aberrations.
Lead sponsor
California Pacific Medical Center Research Institute
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
March 31, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma